(4R)-2,2-DIOXIDO-4-PHENYL-1,2,3-OXATHIAZOLIDINE, N-BOC PROTECTED, 95.0%, 5g

[2-(6-chloro-1H-benzimidazol-2-yl)ethyl]amine dihydrochloride, 95.0%, 1g

4-Butylpyridine, 95.0%, 5g

(2E)-3-[4-(benzyloxy)phenyl]-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 2g

3-Bromo-2,6-dimethoxy-benzoic acid, 95.0%, 25g

ethyl 4-chlorobenzo[h]quinoline-3-carboxylate, 97%, 500mg

2-Cyano-N-(methylcarbamoyl)acetamide, 97%, 5g

2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol sulfate, 95.0%, 100g

N-(1,1-dioxidotetrahydrothien-3-yl)-N-ethylamine hydrochloride, 95.0%, 5g

1,3,5-Tri(2-thienyl)benzene>98.0%(GC)5g

3-Bromo-6-methyl-1H-indole-5-carbonitrile, 98%, 250mg

(2S,5S)-1-(Tert-Butoxycarbonyl)-5-hydroxypiperidine-2-carboxylic acid, 97%, 250mg

Methylhydroxyethylcellulose , 3800-5300 mPas, pulv., 250 g, kunststoffverpackung.